Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.

ID
Name
Pro00044072
Description
Comparison of propofol and sevoflurane as a primary anesthetic for cardiac ablation of atrial fibrillation
Trial arms
Trial start
2016-06-08
Estimated PCD
2023-06-30
Trial end
2024-02-28
Status
Completed
Treatment
propofol
Participant receives propofol as anesthetic for cardiac ablation.
Arms:
propofol
sevoflurane
Participant receives sevoflurane as anesthetic for cardiac ablations.
Arms:
sevoflurane
Size
134
Primary endpoint
procedure duration
1 day
Eligibility criteria
Inclusion Criteria: * have paroxysmal atrial fibrillation * undergoing their first ablation. Exclusion Criteria: * none
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 134, 'type': 'ACTUAL'}}
Updated at
2024-03-20

1 organization

2 products

1 indication

Organization
Medical University of South Carolina
Product
propofol
Indication
Atrial Fibrillation
Product
sevoflurane